These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16732324)

  • 1. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival.
    Kamiyama M; Pozzi A; Yang L; DeBusk LM; Breyer RM; Lin PC
    Oncogene; 2006 Nov; 25(53):7019-28. PubMed ID: 16732324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
    Ansari KM; Sung YM; He G; Fischer SM
    Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
    Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
    Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
    Sung YM; He G; Fischer SM
    Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.
    Brouxhon S; Konger RL; VanBuskirk J; Sheu TJ; Ryan J; Erdle B; Almudevar A; Breyer RM; Scott G; Pentland AP
    J Invest Dermatol; 2007 Feb; 127(2):439-46. PubMed ID: 16977324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
    Sung YM; He G; Hwang DH; Fischer SM
    Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.
    Elberg G; Elberg D; Lewis TV; Guruswamy S; Chen L; Logan CJ; Chan MD; Turman MA
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1622-32. PubMed ID: 17728378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
    Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
    BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
    Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
    Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.
    Keith RL; Geraci MW; Nana-Sinkam SP; Breyer RM; Hudish TM; Meyer AM; Malkinson AM; Dwyer-Nield LD
    Anticancer Res; 2006; 26(4B):2857-61. PubMed ID: 16886605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth.
    Takahashi T; Uehara H; Bando Y; Izumi K
    Mol Cancer Ther; 2008 Sep; 7(9):2807-16. PubMed ID: 18790761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin.
    Chun KS; Langenbach R
    Mol Carcinog; 2011 Jun; 50(6):439-48. PubMed ID: 21268125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.
    Yang L; Yamagata N; Yadav R; Brandon S; Courtney RL; Morrow JD; Shyr Y; Boothby M; Joyce S; Carbone DP; Breyer RM
    J Clin Invest; 2003 Mar; 111(5):727-35. PubMed ID: 12618527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor.
    Chang SH; Liu CH; Wu MT; Hla T
    Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):48-58. PubMed ID: 15967161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor.
    Tilley SL; Audoly LP; Hicks EH; Kim HS; Flannery PJ; Coffman TM; Koller BH
    J Clin Invest; 1999 Jun; 103(11):1539-45. PubMed ID: 10359563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
    Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
    Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways.
    Donnini S; Finetti F; Solito R; Terzuoli E; Sacchetti A; Morbidelli L; Patrignani P; Ziche M
    FASEB J; 2007 Aug; 21(10):2418-30. PubMed ID: 17384145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
    Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP.
    Nagasawa SY; Takuwa N; Sugimoto N; Mabuchi H; Takuwa Y
    Biochem J; 2005 Feb; 385(Pt 3):737-44. PubMed ID: 15377280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia.
    Wang W; Andersson M; Lönnroth C; Svanberg E; Lundholm K
    J Exp Clin Cancer Res; 2005 Mar; 24(1):99-107. PubMed ID: 15943039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.